Searched for
TB VACCINE EFFICACY
Bharat Biotech, Biofabri in tech transfer deal for TB vaccineMTBVAC, the TB vaccine, has undergone Phase I and II clinical trials in India. The vaccine has demonstrated safety and immunogenicity. Base...
mRNA vaccine against tuberculosis shows efficacy in mice, results pave way for larger trialsAustralian researchers have developed a new mRNA vaccine for tuberculosis, showing effective results in mice. The vaccine enhances immunity...
6 crore citizens aged 70 and above brought under Ayushman Bharat; 45 pc of population covered: JP NaddaUnion Health Minister JP Nadda highlights the inclusion of 6 crore citizens aged 70 and above in Ayushman Bharat, covering over 45% of Indi...
Bharat Biotech starts clinical trials of TB jabThe only vaccine in use today--BCG (Bacillus Calmette and Guerin)--is an attenuated variant of the bovine TB pathogen. This is more than a ...
Bharat Biotech begins clinical trials of TB vaccine on adults in IndiaBharat Biotech International Ltd has initiated clinical trials for the Tuberculosis vaccine Mtbvac on adults in India. Developed by the Spa...
Anti-diabetes drugs and patented antivirals to get cheaper, NLEM notifiedFor the first time, patented drugs like anti-TB bedaquiline and delamanid, anti-HIV Dolutegravir and anti-hepatitis C daclatasvir are also ...
Diabetes, patented TB, HIV drugs enter essential listPopular anti-diabetes drug teneligliptin, insulin glargine injection, Common antibiotics like meropenem, Cefuroxime have been included in t...
NIRT plans study on whether booster BCG can help prevent tuberculosisThe efficacy of BCG vaccination in newborns is well known and has a documented protective effect against meningitis and disseminated TB in ...
Gennova closes in on nod for mRNA vax developed in IndiaGennova had in April submitted interim data on India's first indigenously developed mRNA Covid-19 vaccine to the Central Drug Standard Cont...
No one safe until all vaccinated for COVID-19, track hospitalisations, says Johns Hopkins scientistTracking hospitalisation rates which provide an indicator of severity of illness is key, the chief of the Division of Infectious Disease, a...
Serum Institute seeks emergency use authorisation for its rBCG tuberculosis vaccineThe EUA application was submitted on March 22 by Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute ...
BCG shots could slow down Covid-19 spread in first thirty days, says studyThe paper published in Science Advances, a peer-reviewed medical journal brought out by the American Association for the Advancement of Sci...
View: The ‘Covid-19 vaccine’ buzz should silence the anti-vaccination lobbiesThe western societies which had led the smear campaign are those turning most fervently to the same labs for deliverance. Hope has taken th...
Test the BCG-Covid hypothesis furtherClinical trials alone can prove causation. But in a race against time, there’s an easy way to test the hypothesis involving the anti-TB vac...
Serum Institute to test if TB vaccine VPM1002 is effective against Covid-19Serum Institute of India, the world’s largest vaccine manufacturer, will soon start clinical trials in the country to test if tuberculosis ...
GSK's tuberculosis vaccine shows promising resultsThe new vaccine, known as M72/AS01E, was tested at 11 sites in Kenya, South Africa and Zambia in adults whose blood tests showed they had l...
The pill that costs $9,000 in US sells for $70 in IndiaTypically, the price of many expensive patented drugs in European countries like France, Spain or the UK is half of what these cost in the ...
Homoeopathy research showcase at World Summit may spell new hope for HIV, tuberculosis patientsIn a pioneering two-year long study, city-based homoeopath Dr Rajesh Shah has developed a new medicine for AIDS patients, sourced from huma...
New vaccine may fight both tuberculosis and leprosyScientists have found that a variant of an existing vaccine offers stronger protection against both tuberculosis and leprosy.
How to usher in vaccinnovation in IndiaThe challenge is to build on India's recent successes in vaccine research to reach the global cutting edge in producing vaccines for killer...